Better Data for Better Decisions
With COVID (hopefully) in retreat, healthcare delivery organizations (HDOs) can renew their focus on the Quadruple Aim of healthcare. Every HDO has thousands of medical devices used by thousands of nurses, and each costs thousands of dollars. By improving the utilization and management of these devices, HDOs can significantly lower the per capita cost of delivering care and enhance the quality of the work-life for their front-line care teams.
Aligning clinical strategy with regulatory and market objectives through modern forecasting
Aligning evidence for regulatory requirements and global market access requirements depends on accurate forecasting which considers an ever-changing market landscape. As the evidence thresholds for regulatory bodies differ from those of market-access gatekeepers, manufacturers run the risk of misaligned or insufficient evidence to achieve success through both hurdles. Cytel is reshaping the relationship between evidence and forecasting technology and has developed new tools to align clinical strategy with both regulatory and market objectives.
Harnessing the power of Big Data and AI for faster, better, and more efficient studies
As more patients become connected, there’s a new data source that can help us understand and engage patients-- data collected passively through wearables, devices, apps and sensors. Envision being able to gather minute-level data directly from patients, monitor adherence to a protocol outside of brick and mortar walls, and enroll patients into a study within 24 hours -- all of these scenarios are possible in the digital era of medicine.
Using a Unified Cloud-Based Platform for Clinical Research
Clinical trial sponsors conduct thousands of clinical trials annually, across more than a dozen therapeutic areas, multiple geographies, and hundreds of thousands of patients. With the increasing pressure to get high quality data, from a breadth of sources, and in turn, drive better, more effective treatments, sponsors are looking for every advantage in building, setting up, and executing their clinical trials. Many are looking to the cloud to help.
Ride the Wave of Risk-Based Site Monitoring
The FDA’s draft guidance on risk-based approaches to monitoring has generated significant interest and myriad discussions within the industry. However, the rate of adoption of risk-based monitoring approaches has to-date been slower than many industry experts expected. This podcast takes a closer look at the primary concerns expressed along with current approaches, and discusses best practices in adopting a successful risk-based monitoring practice.
Shining Light on Clinical Investigator Cost Budgeting & Planning
This podcast will discuss the drivers of clinical trial investigator costs that sponsors should consider when developing site budgets to ensure regulatory compliance and a more efficient process. The speakers will share best practices as well as pitfalls common to today’s trial budgeting process.
Optimizing data integration for your scientific discovery
Many Pharma companies know that they are sitting on unique data assets that could be used to discover new insights, repurpose failed drug programs, or revisit trial results to identify new segments. However, integrating data across silos continues to be a critical challenge for researchers. Join Kim Ledoux, Thomson Reuters Director of R&D Informatics, for the latest insights on “connecting the dots” in the informatics community.
To promote your podcast with Clinical Informatics News, please contact:
VP, Business Dev.